The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study
Felix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, Sebastian Bauer, Karl Martin Klein, Yvonne Weber, Holger Lerche, Stefan Evers, Stjepana Kovac, Susanne Hallmeyer-Elgner, Götz Winkler, Joachim Springub, Mathias Niedhammer, Erhard Roth, Ilonka Eisensehr, Jörg Berrouschot, Stephan Arnold, Michael Schröder, Anja Beige, Wolfgang H Oertel, Adam Strzelczyk, Anja Haag, Philipp S Reif, Hajo M Hamer, for the LaLiMo Study Group
Journal of Neurology, Neurosurgery & Psychiatry Nov 2012, 83 (11) 1093-1098; DOI: 10.1136/jnnp-2011-301999